Theriva Biologics Financial Overview
Theriva Biologics's market cap is currently $6.57M. The company's EPS TTM is $-0.45; its P/E ratio is -0.04; Theriva Biologics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
